Cutaneous amyloid is a biomarker in early ATTRv neuropathy and progresses across disease stages

OBJECTIVE: To determine the sensitivity and specificity of cutaneous amyloid deposition in relation to patient‐reported measures in the earliest disease stage of hereditary ATTR amyloidosis (ATTRv). METHODS: In a cross‐sectional study, we analyzed 88 individuals with TTR mutations, 47 of whom were i...

Descripción completa

Detalles Bibliográficos
Autores principales: Freeman, Roy, Gonzalez‐Duarte, Alejandra, Barroso, Fabio, Campagnolo, Marta, Rajan, Sharika, Garcia, Jennifer, Kim, Jee Young, Wang, Ningshan, Orellana, Lucas, Gibbons, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463946/
https://www.ncbi.nlm.nih.gov/pubmed/35945901
http://dx.doi.org/10.1002/acn3.51636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463946/
https://www.ncbi.nlm.nih.gov/pubmed/35945901
http://dx.doi.org/10.1002/acn3.51636

Ejemplares similares